European Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Ledger.

Press releases published on October 6, 2026

Oct. 6, 2026

IESE startet das „Global CFO“-Programm

Indeterminate GlobeNewswire

Oct. 6, 2026

IESE launches Global CFO program

Indeterminate GlobeNewswire

Oct. 6, 2026

L’IESE inaugure le parcours « Global CFO Program »

Indeterminate GlobeNewswire

Oct. 6, 2026

Much more than promotion in construction: 12Build supports subcontractors through the entire bidding process

Indeterminate GlobeNewswire

Oct. 6, 2026

Veel meer dan promotie in de bouw: 12Build ondersteunt bouwspecialisten in het héle biedingsproces

Indeterminate GlobeNewswire

Oct. 6, 2026

Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal

Indeterminate GlobeNewswire

Oct. 6, 2026

Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l’innovativo impianto per la riparazione della cartilagine, che sarà presentato all’ICRS Summit in Portogallo.

Indeterminate GlobeNewswire

Oct. 6, 2026

Smith+Nephew lanza en Europa el innovador implante de reparación de cartílago CARTIHEAL™ AGILI-C™, que será protagonista en el Congreso ICRS de Portugal

Indeterminate GlobeNewswire

Oct. 6, 2026

Optimum Strategic Communications to Host 18th Annual Healthcare Investor Conference

Indeterminate GlobeNewswire

Oct. 6, 2026

Resolution Therapeutics to present interim Phase I/II EMERALD study data on RTX001 as a late-breaker at AASLD 2026

Indeterminate GlobeNewswire

Oct. 6, 2026

HI-VIEW RESOURCES COMPLETES 2026 EXPLORATION FIELD PROGRAM IN THE TOODOGGONE MINING DISTRICT, BRITISH COLUMBIA

Indeterminate GlobeNewswire

Oct. 6, 2026

RQ Bio Appoints Gavin Koh as Chief Medical Officer and Strengthens Leadership to Advance RQB01

Indeterminate GlobeNewswire

Oct. 6, 2026

Angelini Ventures and EIB Co-lead $58 Million Series A Financing in Rouge Therapeutics to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire

Oct. 6, 2026

Rewind Therapeutics Secures Additional Financing to Advance Oral GPR17 Remyelination Program

Indeterminate GlobeNewswire

Oct. 6, 2026

RougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire

Oct. 6, 2026

One04 Therapeutics to present late-breaking interim Phase 1 results for CPV-104 in C3 glomerulopathy at ASN Kidney Week followed by Virtual KOL Event

Indeterminate GlobeNewswire

Oct. 6, 2026

Progress on share buyback programme

Indeterminate GlobeNewswire

Oct. 6, 2026

LUBIS EDA Launches FormalOS: Infrastructure for Systematic, Scalable Formal Verification

Indeterminate GlobeNewswire

Oct. 6, 2026

Production update and FTSE 250 Index inclusion

Indeterminate GlobeNewswire

Oct. 6, 2026

Framleiðsluuppfærsla og innganga í FTSE 250 vísitöluna

Indeterminate GlobeNewswire